WO2017191775A1 - 多能性幹細胞の継代方法 - Google Patents
多能性幹細胞の継代方法 Download PDFInfo
- Publication number
- WO2017191775A1 WO2017191775A1 PCT/JP2017/016249 JP2017016249W WO2017191775A1 WO 2017191775 A1 WO2017191775 A1 WO 2017191775A1 JP 2017016249 W JP2017016249 W JP 2017016249W WO 2017191775 A1 WO2017191775 A1 WO 2017191775A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- culture
- medium
- cells
- cell
- pluripotent stem
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0062—General methods for three-dimensional culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
Definitions
- the present disclosure relates to a method for passaging pluripotent stem cells.
- the following techniques are known as techniques relating to the method for subculture of pluripotent stem cells.
- International Publication No. WO 2013/077423 describes a subculture method in which a cell cluster of pluripotent stem cells having an average diameter of about 200 ⁇ m to about 300 ⁇ m is divided through a mesh.
- International Publication No. 2013/077423 describes that the pore size of the mesh is about 50 ⁇ m and the diameter of the divided cell mass is about 80 ⁇ m to about 120 ⁇ m.
- transplantation In order to treat liver disease, heart disease, etc. by cell transplantation, it is considered that transplantation of 1 ⁇ 10 9 or more differentiated cells is necessary for one patient. In order to realize this, it is essential to develop a technique for mass-culturing pluripotent stem cells.
- the conventional enzyme treatment Compared with the passage method according to, the survival rate of cells after passage can be improved.
- the flow rate of the liquid containing pluripotent stem cells passing through the mesh is set to 90 mL to 300 mL per minute as described in International Publication No. 2014/136581 In this case, it takes a long time for the treatment, and it becomes difficult to maintain the homogeneity of the cells.
- the present disclosure provides a method for passaging pluripotent stem cells suitable for mass culture.
- a first aspect according to the present disclosure is a method for subculturing pluripotent stem cells, comprising a culturing step of culturing pluripotent stem cells to obtain a cell mass, and a cell mass of 15 cm / sec to 150 cm / sec.
- a dividing step of dividing the cell mass by passing through a mesh-like membrane having a plurality of through holes each having an opening size of 30 ⁇ m or more and 80 ⁇ m or less at a speed.
- pluripotent stem cells may be cultured in a culture solution containing a polymer compound.
- the average value of the equivalent circle diameter of the divided cell mass is 30 ⁇ m or more and 75 ⁇ m or less.
- the pluripotent stem cell may be an ES cell or an iPS cell.
- a pluripotent stem cell passage method suitable for mass culture can be provided.
- a method for subculturing pluripotent stem cells includes a culturing step of culturing pluripotent stem cells to obtain a cell mass, and the cell mass at a speed of 15 cm / sec to 150 cm / sec.
- the pluripotent stem cell applicable to the exemplary embodiment may be an undifferentiated cell having “self-replicating ability” capable of proliferating while maintaining an undifferentiated state and “multipotent ability” capable of differentiating into all three germ layers.
- pluripotent stem cells include embryonic stem cells (ES cells), induced pluripotent stem cells (iPS cells), embryonic germ cells (EG cells), embryos Embryonal carcinoma cells (EC cells), pluripotent adult progenitor cells (MAP cells), adult pluripotent stem cells (APS cells), Muse cells (multi-lineage differentiating) stress enduring cell).
- ES cells and iPS cells are preferable.
- the animal from which pluripotent stem cells are derived is not particularly limited. Examples of mammals include humans, monkeys, mice, rats, dogs, cows, horses, pigs and the like.
- the animal from which the pluripotent stem cells are derived (that is, the donor) is preferably the same animal as the animal (that is, the recipient) into which the pluripotent stem cells or cells induced to differentiate from the pluripotent stem cells are transplanted. Establishment of pluripotent stem cells may be performed by any known method.
- Whether or not the pluripotent stem cells are maintained in an undifferentiated state can be confirmed by a known method. Examples thereof include a method for confirming the expression of an undifferentiated marker by flow cytometry or immunostaining, and a method for confirming teratoma formation by injecting subcutaneously into an immunodeficient mouse.
- the pluripotent stem cells are preferably grown by suspension culture. Specifically, pluripotent stem cells are filled in a culture vessel together with a medium, and suspension culture is performed until the average value of the equivalent circle diameter of the cell mass of the pluripotent stem cells becomes, for example, 200 ⁇ m to 300 ⁇ m.
- the equivalent circle diameter refers to the diameter of a circle when the region defined by each contour line of the extracted cell mass is regarded as a circle having the same area.
- the average value of the equivalent circle diameter of the cell mass By setting the average value of the equivalent circle diameter of the cell mass to 300 ⁇ m or less, differentiation induction due to a microenvironment formed by cytokines secreted by the cells can be suppressed. In addition, cell necrosis that occurs at the center of the cell mass can be suppressed, and a decrease in the recovery rate of living cells can be suppressed.
- the average value of the equivalent circle diameter of the cell mass to 200 ⁇ m or more, the cell recovery rate can be set to a certain value or more. Note that the size of the cell mass obtained in the culture step can be appropriately changed in consideration of suppression of differentiation induction, cell necrosis, cell recovery rate, and the like.
- the medium applied to the exemplary embodiment is not particularly limited, and includes any known medium used for stem cell culture. Specifically, DMEM (Dulbecco's Modified Eagle's Medium), DMEM: F-12 (Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12), EMEM (Eagle's minimal essential medium), BME (Basal MediumRP, 40, MCDB153, 199, L15, mTeSR1, TeSR2, E8 (Nature Protocols 7: 2029-2040, 2012), and media obtained by adding cell growth factors to these media.
- DMEM Dynabecco's Modified Eagle's Medium
- F-12 Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12
- EMEM Eagle's minimal essential medium
- BME Base MediumRP, 40, MCDB153, 199, L15, mTeSR1, TeSR2, E8 (Nature Protocols 7: 2029-2040, 2012)
- various commonly added components for example, antibiotics such as penicillin and streptomycin; vitamins or vitamin derivatives such as ascorbic acid and retinoic acid; sugar sources such as glucose; amino acids; sodium selenite, chloride Inorganic salts such as sodium; proteins such as transferrin; hormones such as insulin; cytokines such as TGF- ⁇ (transforming growth factor- ⁇ ) and EGF (epidermal growth factor): growth factors; differentiation inhibitory factors; 2-mercaptoethanol, dithio Antioxidants such as threitol may be added.
- the above components may be supplemented to the medium during the culturing of pluripotent stem cells in order to keep the concentration within the intended range throughout the culture period. It is preferable that the medium does not contain serum and serum substitutes from the viewpoint of suppressing the mixing of antigenic substances and infection sources into pluripotent stem cells.
- the pH of the medium is, for example, pH 7.0 to 8.0, preferably pH 7.3 to 7.4.
- the culture may be continued while replacing with a medium having a different composition.
- the medium As a culture medium for suspension culture, it is desirable that the medium has an appropriate viscosity in order to prevent movement of the cell mass and adhesion between the cell masses.
- the moderate viscosity means a viscosity that does not interfere with the medium exchange and does not cause adhesion between cell masses.
- the means for imparting viscosity to the medium is not particularly limited.
- it can be carried out by adding a water-soluble polymer to the medium at an appropriate concentration.
- a water-soluble polymer any water-soluble polymer can be used as long as it can impart an appropriate viscosity to the medium and does not adversely affect cells (has no cytotoxicity) within the concentration range where viscosity can be imparted.
- Polymers can also be used.
- polysaccharides such as cellulose and agarose, methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxyethylmethylcellulose, hydroxypropylmethylcellulose, hydroxyethylethylcellulose, hydroxypropylethylcellulose, ethylhydroxyethylcellulose, dihydroxypropylcellulose, hydroxyethylhydroxypropylcellulose, etc.
- Synthetic polymers such as polysaccharide ether, polyacrylamide, polyethylene oxide, polyvinyl pyrrolidone, ethylene glycol / propylene glycol copolymer, polyethyleneimine polyvinyl methyl ether, polyvinyl alcohol, polyacrylic acid, maleic acid copolymer, collagen, gelatin ,
- Ron acid, dextran, alginate, carrageenan biopolymers such as starch or artificial polymer (for example, elastin-like peptide) that mimics thereof.
- These water-soluble polymers may be used alone or as a mixture of several types of water-soluble polymers. Moreover, you may use the copolymer of these water-soluble polymers.
- it is methylcellulose, polyethylene glycol, polyvinylpyrrolidone, carboxymethylcellulose, or a mixture thereof, more preferably methylcellulose.
- the concentration of methylcellulose is preferably higher than 0.25 w / v% and lower than 0.5 w / v%.
- the concentration of methylcellulose is 0.26 w / v% to 0.3 w / v%, particularly preferably 0.28 w / v%.
- the viscosity at 25 ° C. and a shear rate of 100 s ⁇ 1 is 1.0 mPa ⁇ s to 15 mPa ⁇ s, more preferably 1.0 mPa ⁇ s to 7.5 mPa ⁇ s.
- concentration of the other water-soluble polymer in order to obtain the above-described appropriate viscosity.
- the evaluation of the viscosity at a shear rate of 100 s ⁇ 1 was performed using a viscosity measuring device (MCR301, 25 mm cone plate, 0.098 mm gap, manufactured by Anton Paar Co., Ltd.) with an interval setting of 1.
- the material capable of forming such a structure include a polymer compound, preferably a polymer compound having an anionic functional group.
- the anionic functional group include a carboxy group, a sulfo group, a phosphate group, and salts thereof, and a carboxy group or a salt thereof is preferable.
- the polymer compound include, but are not particularly limited to, a polysaccharide obtained by polymerizing 10 or more monosaccharides (for example, triose, tetrose, pentose, hexose, heptose, etc.), more preferably And acidic polysaccharides having an anionic functional group.
- a polysaccharide obtained by polymerizing 10 or more monosaccharides for example, triose, tetrose, pentose, hexose, heptose, etc.
- acidic polysaccharides having an anionic functional group for example, triose, tetrose, pentose, hexose, heptose, etc.
- hyaluronic acid gellan gum, deacylated gellan gum, rhamzan gum, diyutan gum, xanthan gum, carrageenan, xanthan gum, hexuronic acid, fucoidan, pectin, pectinic acid, pectinic acid, heparan sulfate, heparin, heparitin sulfate, kerato
- examples thereof include those composed of one or more kinds from the group consisting of sulfuric acid, chondroitin sulfate, deltaman sulfate, rhamnan sulfate and salts thereof.
- the polysaccharide is preferably hyaluronic acid, gellan gum, deacylated gellan gum, diutan gum, xanthan gum, carrageenan or salts thereof, which can float cells and cell masses at low concentrations and In view of ease of recovery, deacylated gellan gum is most preferable.
- deacylated gellan gum When deacylated gellan gum is mixed with a liquid medium, it takes up metal ions (for example, calcium ions) in the liquid medium, forms an amorphous structure via the metal ions, and floats the cells.
- the viscosity of the medium composition prepared containing deacylated gellan gum is 8 mPa ⁇ s or less, preferably 4 mPa ⁇ s or less at a shear rate of 1000 s ⁇ 1 , taking into account the ease of cell recovery. Then, it is more preferably 1.0 mPa ⁇ s or more and 2 mPa ⁇ s or less.
- the viscosity at a shear rate of 1000 s ⁇ 1 was evaluated at an interval setting of 1 using a viscosity measuring apparatus (MCR301, 25 mm cone plate, 0.098 mm gap manufactured by Anton Paar).
- pluripotent stem cells that have been attached and cultured are dissociated by an enzyme treatment, and, for example, about 1 ⁇ 10 5 to 5 ⁇ 10 6 cells / ml, preferably about 2 ⁇ 10 5 to 2 ⁇ 10 6 in a culture vessel. Seeded to a cell density of 6 cells / ml, and in an atmosphere of about 1% to 10%, preferably about 2% to 5% CO 2 at about 30 ° C. to 40 ° C., preferably about 37 ° C. It is carried out for 1 to 7 days, preferably 3 to 6 days, more preferably 4 to 5 days. During the culture period, the medium in the culture vessel is preferably replaced with a fresh medium every one or two days.
- the cells divide once every about 24 hours. Therefore, assuming that the circle equivalent diameter of the cell mass of the pluripotent stem cells at the start of suspension culture is about 80 ⁇ m, the cells are cultured for 4 or 5 days. The mass is thought to grow to 200 ⁇ m to 300 ⁇ m.
- FIG. 1A is a cross-sectional view showing a configuration of a dividing apparatus 400 used in the dividing process.
- the dividing device 400 includes a mesh 401 and a case 402.
- the case 402 has an inflow port 411 and an outflow port 412.
- the mesh 401 is provided between the inlet 411 and the outlet 412 inside the case 402. That is, the inflow port 411 and the outflow port 412 are separated by the mesh 401.
- FIG. 1B is a plan view showing the configuration of the mesh 401.
- the mesh 401 is configured by knitting fiber members made of a synthetic resin such as nylon or polyethylene terephthalate or a metal such as stainless steel in a lattice shape. That is, the mesh 401 is a mesh-like film having a plurality of through holes 420. As shown in FIG. 1B, when the warp and weft constituting the mesh 401 are knitted at the same interval, the shape of the through hole 420 becomes a square.
- a cell mass of pluripotent stem cells is caused to flow in from the inlet 411 of the dividing device 400 together with the culture medium and out of the outlet 412.
- the cell mass of pluripotent stem cells that has flowed from the inflow port 411 is divided into cell clusters of smaller size when passing through the mesh 401.
- the speed at which the cell cluster of pluripotent stem cells passes through the mesh 401 is 15 cm / sec or more and 150 cm / sec or less.
- the division processing amount per second can be 150 cm 3 or more.
- the division process can be completed in about 10 minutes, and the cell homogeneity can be maintained.
- it is possible to suppress damage to cells due to division by setting the speed at which the cell mass of pluripotent stem cells passes through the mesh 401 to 15 cm / sec or more and 150 cm / sec or less.
- the speed at which the cell mass of pluripotent stem cells passes through the mesh 401 is more preferably 30 cm / sec or more and 120 cm / sec or less, and still more preferably 50 cm / sec, from the viewpoint of processing ability and mitigating damage to the cells. It is 100 cm / sec or less.
- the opening size of the through-hole 420 of the mesh 401 is preferably 30 ⁇ m or more and 80 ⁇ m or less, more preferably 40 ⁇ m or more and 70 ⁇ m or less, and typically 50 ⁇ m.
- the opening dimension means the length of one side of the square when the shape of the through hole 420 is a square as shown in FIG. 1B, and the diameter of the circle when the shape of the through hole 420 is a circle. Means.
- the average value of the equivalent circle diameter of the cell mass after the division is preferably 30 ⁇ m or more and 75 ⁇ m or less.
- the average value of the equivalent circle diameter of the cell mass after the division is measured as follows. For example, 300 cell masses divided by passing through the mesh 401 are randomly extracted by microscopic observation, each circle equivalent diameter of the extracted cell mass is measured, and an average value of the measured circle equivalent diameters is calculated. .
- the measurement of the equivalent circle diameter of the cell mass is preferably completed before 1 hour elapses after the cell mass is divided.
- FIG. 2A to FIG. 2F show the results immediately after the division, 1 hour after the division, 2 hours after the division, 3 hours after the division, 4 hours after the division, 24 hours after the division, respectively.
- FIG. 2A and FIG. 2B in the period until 1 hour elapses after the division, the state of the cell mass remains the state immediately after the division.
- FIGS. 2C to 2F when 2 hours have passed after the division, single cells as dead cells are detached from the surface of the cell mass with the passage of time, and the number of single cells increases. Therefore, by completing measurement of the size of the cell mass before 1 hour has elapsed after the division, it is possible to obtain appropriate information as statistical information of the cell mass immediately after the division.
- X be the number of cell clusters having a circle equivalent diameter of 30 ⁇ m or more and less than 40 ⁇ m among the cell clusters divided in the dividing step according to the present exemplary embodiment.
- Y be the number of cell clusters having a circle-equivalent diameter of 40 ⁇ m or more and less than 300 ⁇ m among the cell clusters divided in the dividing step according to this exemplary embodiment.
- the distribution of the equivalent circle diameter of the divided cell mass satisfies the following formula (1). 1 ⁇ X / Y ⁇ 3 (1)
- Cell masses with an equivalent circle diameter of 30 ⁇ m or more and less than 40 ⁇ m are considered to be relatively damaged by division, but such relatively damaged cells actively secrete proteins that contribute to recovery from damage. It is considered a thing. This protein is thought to contribute to the recovery of damage not only to self cells but also to other cells.
- a cell mass having an equivalent circle diameter of 40 ⁇ m or more and less than 300 ⁇ m is considered to have a relatively small damage due to division, and a survival rate after division is considered to be relatively high. Therefore, it is considered that the proliferation rate of cells after passage (that is, after division) can be maximized by the distribution of the equivalent circle diameter of the cell mass after division satisfying the above equation (1).
- the opening size of the through-hole 420 of the mesh 401 is 30 ⁇ m or more and 80 ⁇ m or less, and the speed at which the cell mass of the pluripotent stem cell passes through the mesh 401 is 15 cm / sec or more and 150 cm / sec or less. It becomes easy to control the average value of the equivalent circle diameter to be 30 ⁇ m or more and 75 ⁇ m or less and satisfy the above expression (1) in the distribution of the equivalent circle diameter of the divided cell mass. Therefore, it is possible to efficiently divide cell clusters while suppressing damage to pluripotent stem cells, which is suitable for mass culture of pluripotent stem cells.
- FIG. 3 is a diagram illustrating a configuration of the cell culture device 10 according to an exemplary embodiment of the present disclosure.
- the cell culture apparatus 10 includes a cell supply unit 100, a medium supply unit 110, a diluent supply unit 120, and a frozen solution supply unit 130. Further, the cell culture device 10 includes a culture container 20, a storage container 30, a division processing unit 40, a waste liquid collection container 16 and a freezing unit 17.
- the cell culture device 10 accommodates the cells supplied from the cell supply unit 100 in the culture container 20 together with the culture medium (culture solution) supplied from the medium supply unit 110, and floats the cells in the culture medium in the culture container 20. Incubate in the state of being allowed to
- the cell supply unit 100 includes a cell storage unit 101 that stores cells to be cultured by the cell culture apparatus 10 in a frozen state, and a cell that is stored in the cell storage unit 101, including the pipe c1. And a pump P1 fed to the flow path F3. Moreover, the cell supply part 100 has the opening-and-closing valve V1 provided in the downstream of the pump P1 of the piping which connects the cell accommodating part 101 and the piping c1. The cells stored in the cell storage unit 101 are sent to the flow path F3 when the pump P1 is driven and the open / close valve V1 is opened.
- the medium supply unit 110 includes medium storage units 111 and 114 that store a medium (culture solution) used for cell culture, and a pump P2 that sends the medium stored in each of the medium storage units 111 and 114 to the flow path F3. And P3, and filters 113 and 116 for sterilizing the media sent from the pumps P2 and P3, respectively. Further, the culture medium supply unit 110 includes an opening / closing valve V2 provided on the downstream side of the filter 113, a pipe connecting the culture medium storage unit 111 and the pipe c1, and a pipe connecting the culture medium storage unit 114 and the pipe c1. And an open / close valve V3 provided on the downstream side of the filter 116.
- the culture medium supply unit 110 includes the first system including the culture medium storage unit 111, the pump P2, the filter 113, and the open / close valve V2, the culture medium storage unit 114, the pump P3, the filter 116, and A two-system culture medium supply function including a second system including the opening / closing valve V3 is provided, and two different types of culture media can be supplied.
- the number of lines in the medium supply unit 110 can be appropriately increased or decreased according to a cell culture protocol or the like. That is, the culture medium supply unit 110 may be configured to be able to supply three or more types of culture media, or may be configured to be capable of supplying one type of culture medium.
- the medium accommodated in the medium accommodating part 111 is sent to the flow path F3 when the pump P2 is driven and the open / close valve V2 is opened.
- the medium stored in the medium storage unit 114 is sent to the flow path F3 when the pump P3 is driven and the open / close valve V3 is opened.
- the diluent supply unit 120 supplies a diluent storage unit 121 that stores a diluent used in a dilution process appropriately performed in the cell culture process, and a diluent stored in the diluent storage unit 121 to the flow path F3. It has the pump P4 to send out and the filter 123 for disinfecting the dilution liquid sent out from the pump P4.
- the diluent supply unit 120 includes an open / close valve V4 provided on the downstream side of the filter 123 in a pipe connecting the diluent storage part 121 and the pipe c1. The diluent stored in the diluent storage unit 121 is sent to the flow path F3 when the pump P4 is driven and the open / close valve V4 is opened.
- the freezing liquid supply unit 130 includes a freezing liquid storage unit 131 that stores a freezing liquid used when the cultured cells are cryopreserved in the freezing unit 17, and a freezing liquid stored in the freezing liquid storage unit 131. It has the pump P5 sent to F3, and the filter 133 for disinfecting the frozen liquid sent from the pump P5.
- the frozen liquid supply unit 130 includes an opening / closing valve V5 provided on the downstream side of the filter 133 in a pipe connecting the frozen liquid storage unit 131, the pump P5, and the filter 133.
- the frozen liquid stored in the frozen liquid storage part 131 is sent to the flow path F3 when the pump P5 is driven and the open / close valve V5 is opened.
- the culture container 20 is a container for storing the cells supplied from the cell supply unit 100 together with the medium supplied from the medium supply unit 110 and culturing the stored cells.
- the form of the culture container 20 is not particularly limited, and for example, a glass or stainless steel container or a container having a plastic bag form can be used.
- the culture container 20 includes an inlet 21 for allowing cells and a medium to flow into the culture container 20, and an outlet 22 for allowing cells and a medium contained in the culture container 20 to flow out of the culture container 20. Have.
- the culture vessel 20 is housed in an incubator 24 that is controlled and sealed at, for example, a temperature of 30 ° C. to 40 ° C. (preferably 37 ° C.) and a CO 2 concentration of 2% to 10% (preferably 5%).
- the incubator 24 includes a gas supply mechanism 25 for supplying oxygen (O 2 ) and carbon dioxide (CO 2 ) to cells housed in the culture vessel 20 together with the culture medium.
- the incubator 24 includes a pressure adjustment mechanism 26 that adjusts the pressure in the culture vessel 20.
- the pressure adjustment mechanism 26 pressurizes the atmosphere in the culture container 20 by introducing air into the culture container 20 or discharges the atmosphere in the culture container 20 to the outside to discharge the atmosphere in the culture container 20 to the atmosphere. To release.
- the pressure adjusting mechanism 26 causes the cells and the medium contained in the culture vessel 20 to flow out into the circulation channel F1 by increasing the pressure in the culture vessel 20 to be higher than the pressure in the circulation channel F1 described later.
- the cell culture device 10 has a circulation flow path F1 including pipes a1 to a7 that connect the outlet 22 and the inlet 21 of the culture vessel 20.
- the cells and medium accommodated in the culture vessel 20 circulate in the circulation flow path F1 during the culture process.
- the cells and medium flowing in the circulation flow path F1 flow into the culture container 20 via the inflow port 21, and the cells and medium accommodated in the culture container 20 circulate through the outflow port 22. It flows out into the path F1.
- An opening / closing valve V11 is provided in the pipe a7 that constitutes the circulation channel F1 connected to the inlet 21 of the culture vessel 20, and the pipe a1 that constitutes the circulation channel F1 connected to the outlet 22 of the culture vessel 20 is provided. Is provided with an open / close valve V12.
- the on-off valve V11 is in an open state when cells and a medium are allowed to flow into the culture vessel 20 from the circulation channel F1, and is closed in other cases.
- the on-off valve V12 is opened when the cells and the medium are allowed to flow out from the culture vessel 20 into the circulation channel F1, and is otherwise closed.
- the flow path F3 constituted by the pipe c1 connected to the cell supply section 100, the culture medium supply section 110, the diluent supply section 120, and the frozen liquid supply section 130 is connected to the circulation flow path F1 at the connection site X3. That is, the cells stored in the cell storage unit 101, the culture medium stored in the culture medium storage units 111 and 114, the diluent stored in the diluent storage unit 121, and the frozen solution stored in the freezing solution storage unit 131, It is supplied into the circulation flow path F1 via the flow path F3 and the connection part X3.
- the pipe c1 constituting the flow path F3 is provided with an open / close valve V6 in the vicinity of the connection site X3.
- the on-off valve V6 is opened when cells, a medium, a diluent, and a frozen solution are supplied from the cell supply unit 100, the medium supply unit 110, the diluent supply unit 120, and the frozen solution supply unit 130, respectively, into the circulation channel F1. In other cases, it is closed.
- the storage container 30 is provided in the circulation channel F1, that is, in the middle of the circulation channel F1.
- the storage container 30 is a container for temporarily storing cells, a medium, a diluting solution, and a frozen solution flowing in the circulation flow path F1, and a culture start process, a medium replacement process, which will be described later, performed during the culture period, Used in splitting and freezing processes.
- the form of the storage container 30 is not particularly limited, and for example, a glass or stainless steel container or a container having a plastic bag form can be used.
- the storage container 30 includes an inlet 31 for allowing cells, medium, diluent and frozen liquid flowing in the circulation channel F1 to flow into the storage container 30, and cells, medium, diluent and An outlet 32 is provided for allowing the frozen liquid to flow into the circulation flow path F1.
- the inflow port 31 of the storage container 30 is connected to the outflow port 22 of the culture container 20 by pipes a1, a2 and a3 constituting the circulation flow path F1.
- the outflow port 32 of the storage container 30 is connected to the inflow port 21 of the culture container 20 by pipes a4, a5, a6, and a7 that constitute the circulation flow path F1.
- connection part X3 to which the circulation channel F1 and the channel F3 are connected is disposed in the vicinity of the inlet 31 of the storage container 30, but the circulation channel F1 and the channel
- the connection position with F3 can be arranged at any position in the circulation flow path F1.
- An opening / closing valve V13 is provided in the vicinity of the inlet 31 of the storage container 30 in the pipe a2 constituting the circulation flow path F1.
- the on-off valve V13 is in an open state when cells, a medium, and the like are allowed to flow into the storage container 30 from the circulation channel F1, and is closed in other cases.
- An opening / closing valve V14 is provided in the vicinity of the outlet 32 of the storage container 30 in the pipe a5 that constitutes the circulation flow path F1.
- the on-off valve V14 is opened when cells, a medium, and the like are transferred from the storage container 30 into the circulation channel F1 to the culture container 20, the division processing unit 40, and the freezing unit 17, and is otherwise closed. State.
- the storage container 30 includes a pressure adjustment mechanism 33 that adjusts the pressure in the storage container 30.
- the pressure adjustment mechanism 33 pressurizes the atmosphere in the storage container 30 by introducing air into the storage container 30 or discharges the atmosphere in the storage container 30 to the outside to discharge the atmosphere in the storage container 30 to the atmosphere. To release.
- the pressure adjustment mechanism 33 circulates the cells, the culture medium, the diluted solution, and the frozen solution stored in the storage container 30 from the outflow port 32 by increasing the pressure in the storage container 30 to be higher than the pressure in the circulation channel F1. It flows out into the flow path F1.
- the cell culture device 10 includes a connection part X1 located between the outlet 32 of the storage container 30 and the inlet 21 of the culture container 20 in the circulation channel F1, and the storage container 30 in the circulation channel F1. It has the flow path F2 comprised including the piping b1 and b2 which connect the connection site
- FIG. Cells, a medium, and the like flowing in the circulation flow path F1 can flow into the flow path F2 via the connection site X1.
- cells, culture medium, and the like flowing in the flow path F2 can flow into the circulation flow path F1 via the connection portion X2.
- the division processing unit 40 is provided in the flow path F2, that is, in the middle of the flow path F2.
- the division processing unit 40 includes the above-described dividing device 400 shown in FIG. 1A in the culture vessel 20.
- the division processing unit 40 divides the cell mass flowing into the flow path F2 from the circulation flow path F1 via the connection portion X1 in the division device 400.
- the cells subjected to the division process flow out into the circulation channel F1 via the connection part X2.
- the division processing unit 40 includes a liquid feeding unit 450 connected to the inlet 411 (see FIG. 1A) of the dividing device 400.
- the liquid feeding unit 450 has a liquid feeding mechanism for feeding a medium containing cell clusters to the dividing device 400.
- the liquid feeding unit 450 may have a so-called syringe pump configuration that pushes out the liquid stored in the cylindrical container with a piston.
- the speed at which the cell cluster of pluripotent stem cells passes through the mesh 401 of the dividing device 400 is controlled by the liquid feeding unit 450.
- the liquid feeding unit 450 feeds the liquid at a constant speed within a range of 15 cm / sec or more and 150 cm / sec or less at which the cell mass of pluripotent stem cells passes through the mesh 401 of the dividing device 400.
- an opening / closing valve V21 is provided in the vicinity of the connection portion X1.
- the on-off valve V21 is opened when cells or the like are transferred from the storage container 30 to the division processing unit 40, and is closed otherwise.
- an opening / closing valve V22 is provided in the vicinity of the connection site X2 in the pipe b2 that is disposed on the downstream side of the division processing unit 40 and that constitutes the flow path F2.
- the on-off valve V22 is opened when the cells subjected to the division process by the division processing unit 40 are allowed to flow out into the circulation flow path F1, and is otherwise closed.
- an opening / closing valve V15 is provided in the vicinity of the connection site X2 and upstream of the connection site X2.
- the on-off valve V15 is opened when cells and culture medium are transferred from the culture vessel 20 to the storage vessel 30, and is closed otherwise.
- the cell culture device 10 is located between the outlet 32 of the storage container 30 and the inlet 21 of the culture container 20 in the circulation flow path F1 and upstream of the connection site X1 (near the storage container 30).
- connection part X4 to be performed it has flow path F4 comprised including piping d1 connected to circulation flow path F1.
- a waste liquid collection container 16 is provided at the end of the flow path F4.
- the waste liquid recovery container 16 is a container for recovering the waste liquid flowing into the flow path F4 from the circulation flow path F1 via the connection part X4.
- the waste liquid collected in the waste liquid collection container 16 includes a used medium, a used diluent, a frozen liquid accompanying the cells supplied in a frozen state from the cell supply unit 100, and the like.
- the form of the waste liquid collection container 16 is not particularly limited. For example, a glass or stainless steel container or a container having a plastic bag form can be used.
- An open / close valve V31 is provided in the vicinity of the connection site X4 in the pipe d1 constituting the flow path F4.
- the on-off valve V31 is opened when the waste liquid flowing out from the storage container 30 is collected in the waste liquid collection container 16, and is closed otherwise.
- the cell culture device 10 has a flow path F5 configured to include a pipe e1 connected to the circulation flow path F1 at the connection site X1.
- the freezing part 17 is provided in the edge part of the flow path F5.
- the freezing unit 17 includes a storage container 17a that stores the cells flowing into the flow path F5 from the circulation flow path F1 via the connection portion X1 together with the freezing liquid supplied from the freezing liquid supply unit 130.
- the storage container 17a may have a form of, for example, a vial, a cryotube, or a bag.
- the freezing part 17 may be configured to include a freezer that freezes the cells and the frozen liquid stored in the storage container 17a.
- the freezing part 17 may be provided with the tank filled with liquid nitrogen, and may be comprised so that the storage container 17a can be accommodated in a tank. Moreover, the freezing part 17 may be comprised including the cryo-library (trademark) system made from Taiyo Nippon Sanso, for example.
- An open / close valve V41 is provided in the vicinity of the connection site X1 in the pipe e1 constituting the flow path F5. The on-off valve V41 is opened when the cells and the frozen liquid are transferred from the storage container 30 to the freezing unit 17, and is otherwise closed.
- the connection position of the flow path F5 and the circulation flow path F1 may be any position as long as it is between the outlet 32 of the storage container 30 and the inlet 21 of the culture container 20. Further, when it is not necessary to cryopreserve the cells, the freezing unit 17 can be omitted.
- Control unit> The control unit 18 comprehensively controls the operations of the pumps P1 to P5, the on-off valves V1 to V5, V11 to V16, V21, V22, V31 and V41, the gas supply mechanism 25, and the pressure adjustment mechanisms 26, 33 and 43. As a result, cell culture in accordance with a predetermined cell culture protocol is automatically performed without human intervention.
- the electrical connection wiring between the control unit 18 and each of the above-described components controlled by the control unit 18 is omitted from the viewpoint of avoiding the complexity of the drawing.
- the cell culture device 10 performs, for example, a culture start process, a medium exchange process, a division process, and a freezing process exemplified below.
- the control unit 18 uses the open / close valves V1 to V5, V11 to V16, V21, V22, V31 and V41, pumps P1 to P5, pressure This is realized by controlling the operations of the adjusting mechanisms 26, 33 and 43.
- FIG. 4 is a diagram illustrating the flow of cells, culture medium, and the like when the cell culture device 10 performs a culture start process.
- FIG. 4 shows the correspondence between the flow of cells, culture medium, etc., and the following processing steps.
- step S1 the on-off valves V1, V4 and V6 are opened, and the pumps P1 and P4 are driven.
- the cells stored in the cell storage unit 101 in a frozen state and the diluent stored in the diluent storage unit 121 flow into the storage container 30 via the flow path F3 and the circulation flow path F1.
- step S2 a concentration process for removing the frozen solution and the diluted solution from the mixture stored in the storage container 30 and the frozen solution and the diluted solution accompanying the cells is performed.
- the concentration process is performed, for example, by causing the cells stored in the storage container 30 together with the diluent to settle in the storage container 30 (natural sedimentation), and removing the supernatant liquid containing the diluent and the frozen liquid. .
- the open / close valve V14 is opened for a short period of time. Accordingly, the cells are allowed to flow out of the storage container 30 while leaving the supernatant in the storage container 30 and are retained in the pipe a5.
- the open / close valve V14 is closed and the open / close valve V31 is opened.
- the waste liquid containing the diluent and the frozen liquid remaining in the storage container 30 flows out from the outlet 32 of the storage container 30 and is recovered in the waste liquid recovery container 16 via the flow path F4.
- the transfer of cells from the storage container 30 to the pipe a5 and the transfer of the diluent and the frozen liquid from the storage container 30 to the waste liquid collection container 16 are performed by pressurizing the atmosphere in the storage container 30 by the pressure adjustment mechanism 33. Is called.
- step S3 the on-off valves V2, V3 and V6 are opened, and the pumps P2 and P3 are driven.
- the culture medium A and the culture medium B accommodated in the culture medium accommodating parts 111 and 114 flow in in the storage container 30 via the flow path F3 and the circulation flow path F1.
- the open / close valve V14 is opened, and the mixed medium composed of the medium A and the medium B flows out of the storage container 30 and joins the cells staying in the pipe a5.
- step S4 the on-off valves V14, V16 and V21 are opened. Further, the atmosphere in the storage container 30 is pressurized by the pressure adjusting mechanism 33. As a result, the cells and the medium that stay in the pipe a ⁇ b> 5 flow into the flow path F ⁇ b> 2 via the connection part X ⁇ b> 1 and flow into the division processing unit 40. The cells that have flowed into the division processing unit 40 are subjected to division processing in the division device 400. The division process here is performed for the purpose of crushing the frozen cells.
- step S5 the open / close valves V22 and V13 are opened, and the cells subjected to the division process flow out into the circulation flow path F1 through the connection portion X2 together with the culture medium, and are transferred into the storage container 30. .
- step S6 the on-off valves V14, V16 and V11 are opened. Further, the atmosphere in the storage container 30 is pressurized by the pressure adjusting mechanism 33. Thereby, the cells and culture medium stored in the storage container 30 flow into the culture container 20 via the circulation flow path F1.
- the culture start process is completed through the above steps S1 to S6.
- the concentration process and the supply of a new medium are performed before the division process. However, the concentration process and the supply of a new medium may be performed after the division process.
- FIG. 5 is a diagram illustrating a flow of cells, a medium, and the like when the cell culture device 10 performs a medium replacement process.
- FIG. 5 shows the correspondence between the flow of cells and culture medium, etc., and the following processing steps.
- step S11 the on-off valves V12, V15, and V13 are opened.
- the atmosphere in the culture vessel 20 is pressurized by the pressure adjustment mechanism 26.
- step S12 a concentration process for removing the used medium from the mixture containing the cells stored in the storage container 30 and the used medium is performed.
- the concentration process is performed in the same procedure as the process in step S2 of the culture start process described above.
- the concentration treatment the used medium is collected in the waste liquid collection container 16, and the cells stay in the pipe a5.
- a diluent may be introduced into the storage container 30.
- step S13 the on-off valves V2, V3 and V6 are opened, and the pumps P2 and P3 are driven. Thereby, the new culture medium A and the new culture medium B accommodated in the culture medium accommodating parts 111 and 114 flow in in the storage container 30 via the flow path F3 and the circulation flow path F1. Thereafter, the open / close valve V14 is opened, and a new medium including the medium A and the medium B flows out of the storage container 30 and merges with the cells staying in the pipe a5.
- step S14 the on-off valves V14, V16 and V11 are opened. Further, the atmosphere in the storage container 30 is pressurized by the pressure adjusting mechanism 33. As a result, the cells and the new medium that stay in the pipe a5 flow into the culture vessel 20. The cells accommodated in the culture vessel 20 are cultured with a new medium. The medium replacement process is completed through the processes in steps S11 to S14 described above.
- FIG. 6 is a diagram illustrating a flow of cells, a medium, and the like when the cell culture device 10 performs the division process.
- FIG. 6 shows the correspondence between the flow of cells and culture medium and the following processing steps.
- step S21 the on-off valves V12, V15 and V13 are opened.
- the atmosphere in the culture vessel 20 is pressurized by the pressure adjusting mechanism 26, and the cell clumps and used medium generated in the culture vessel 20 flow out into the circulation flow path F 1 and are transferred into the storage vessel 30.
- step S22 a concentration process for removing the used medium from the mixture containing the cell mass and the used medium stored in the storage container 30 is performed.
- the concentration process is performed in the same procedure as the process in step S2 of the culture start process described above.
- the concentration treatment the used medium is recovered in the waste liquid recovery container 16, and the cell mass stays in the pipe a5.
- a diluent may be introduced into the storage container 30.
- step S23 the on-off valves V2, V3 and V6 are opened, and the pumps P2 and P3 are driven. Thereby, the new culture medium A and the new culture medium B accommodated in the culture medium accommodating parts 111 and 114 flow in in the storage container 30 via the flow path F3 and the circulation flow path F1. Thereafter, the open / close valve V14 is opened, and a new medium including the medium A and the medium B flows out of the storage container 30 and merges with the cell mass remaining in the pipe a5.
- step S24 the on-off valves V14, V16 and V21 are opened. Further, the atmosphere in the storage container 30 is pressurized by the pressure adjusting mechanism 33. Thereby, the cell mass and culture medium which remain
- FIG. The cells that have flowed into the division processing unit 40 are divided by the dividing device 400.
- the liquid feeding unit 450 performs liquid feeding at a constant speed within a range in which the cell mass of the pluripotent stem cells passes through the mesh 401 of the dividing device 400 is 15 cm / sec or more and 150 cm / sec or less.
- step S25 the open / close valves V22 and V13 are opened, and the cells subjected to the division process flow out into the circulation flow path F1 through the connection portion X2 together with the culture medium, and are transferred into the storage container 30. .
- step S26 the on-off valves V14, V16 and V11 are opened. Further, the atmosphere in the storage container 30 is pressurized by the pressure adjusting mechanism 33. As a result, the cells that have been subjected to the division process stored in the storage container 30 and the new medium flow into the culture container 20. In the culture container 20, the culture of the cells subjected to the division process is continued. The division process is completed through the above steps S21 to S26. That is, cell passage is completed.
- the concentration process and the supply of a new medium are performed before the division process, but the concentration process and the supply of a new medium may be performed after the division process.
- FIG. 7 is a diagram illustrating a flow of cells, a medium, and the like when the cell culture device 10 performs a freezing process.
- FIG. 7 shows the correspondence between the flow of cells and culture medium and the following processing steps.
- step S41 the on-off valves V12, V15, and V13 are opened.
- the atmosphere in the culture vessel 20 is pressurized by the pressure adjustment mechanism 26.
- step S42 a concentration process for removing the used medium from the mixture containing the cells stored in the storage container 30 and the used medium is performed.
- the concentration process is performed in the same procedure as the process in step S2 of the culture start process described above.
- the concentration treatment the used medium is collected in the waste liquid collection container 16, and the cells stay in the pipe a5.
- a diluent may be introduced into the storage container 30.
- step S43 the on-off valves V5 and V6 are opened, and the pump P5 is driven. Thereby, the frozen liquid stored in the frozen liquid storage part 131 flows into the storage container 30 via the flow path F3 and the circulation flow path F1. Thereafter, the open / close valve V14 is opened, and the frozen liquid flows out of the storage container 30 and merges with the cells staying in the pipe a5.
- step S44 the on-off valves V14, V16 and V41 are opened. Further, the atmosphere in the storage container 30 is pressurized by the pressure adjusting mechanism 33. Thereby, the cells and the frozen liquid staying in the pipe a5 are accommodated in the storage container 17a of the freezing part 17 via the flow path F5. The freezing unit 17 freezes the cells accommodated in the storage container 17a together with the freezing solution. The freezing process is completed through the above steps S41 to S44.
- cryopreserving cells for example, the method described in Japanese Patent No. 4705473 may be applied.
- This method includes the step of rapidly freezing the cells in a medium containing a predetermined amount of dimethyl sulfoxide (DMSO), propylene glycol, acetamide and a medium.
- DMSO dimethyl sulfoxide
- the method described in Japanese Patent No. 4223961 may be applied.
- This method is a method for cryopreserving cells using a cryopreservation solution containing at least one selected from the group consisting of dimethyl sulfoxide, glycerin, ethylene glycol, propylene glycol, and polyvinylpyrrolidone as a cryoprotectant at a predetermined concentration.
- a step of suspending cells in a cryopreservation solution a cooling step in which the cryopreservation solution is cooled to ⁇ 80 ° C. or lower at a predetermined cooling rate, and a storage step in which the cryopreservation solution is stored at ⁇ 80 ° C. or lower. including.
- the type of medium to be used is cell culture. It can be appropriately changed according to the protocol. That is, the medium to be used may be one type or three or more types according to the culture protocol.
- the cell culture device 10 can automatically perform cell culture without human intervention by the control unit 18 executing a cell culture processing program exemplified below.
- FIG. 8 is a flowchart showing the flow of processing in the cell culture program executed by the control unit 18.
- step S ⁇ b> 101 the control unit 18 executes the above-described culture start process to house the cells supplied from the cell supply unit 100 and the medium supplied from the medium supply unit 110 in the culture container 20, and perform cell culture. To start.
- step S102 the control unit 18 performs the medium replacement process (first time) after the elapse of a predetermined period from the start of the cell culture, so that the used medium in the culture container 20 is stored in the medium storage unit.
- the medium is replaced with a new medium contained in 111 and 114, and the cell culture is continued.
- step S103 the control unit 18 performs the medium replacement process (second time) after the lapse of a predetermined period after the first medium replacement process, whereby the used medium in the culture container 20 is removed. Then, the medium is replaced with a new medium accommodated in the medium accommodating part 111 and 114, and the cell culture is continued.
- step S104 the control unit 18 continues the cell culture by dividing the cell mass by performing the above-described division process after a predetermined period of time has elapsed since the second medium exchange process.
- step S105 the control unit 18 determines whether or not the number of culture cycles in which the processing in steps S102 to S104 described above is one cycle has reached a predetermined number. When it is determined that the number of culture cycles has not reached the predetermined number, the control unit 18 returns the process to step S102. On the other hand, if the control unit 18 determines that the number of culture cycles has reached a predetermined number, the process proceeds to step S106. As the culture cycle progresses, the cell culture scale increases.
- step S106 the control unit 18 stores the cells cultured by performing the above-described freezing process in the storage container 17a of the freezing unit 17 and cryopreserves them.
- the medium exchange process is performed twice in one cycle of the culture cycle.
- the number of times of performing the medium exchange process in one cycle of the culture cycle can be changed as appropriate. .
- the cell culture device 10 has the circulation flow path F ⁇ b> 1 that connects the inlet 21 and the outlet 22 of the culture vessel 20.
- the cell culture apparatus 10 has the storage container 30 provided in the circulation flow path F1.
- the storage container 30 has an inlet 31 connected to the outlet 22 of the culture container 20 and an outlet 32 connected to the inlet 21 of the culture container 20.
- the storage container 30 is used for a concentration process or the like performed in the culture start process, the medium exchange process, the division process, and the freezing process.
- the cell culture device 10 includes the connection part X1 in the circulation channel F1 positioned between the outlet 32 of the storage container 30 and the inlet 21 of the culture container 20, the inlet 31 of the storage container 30, and the culture container.
- the cell culture device 10 is provided in the flow path F2, divides the cell mass flowing from the circulation flow path F1 via the connection part X1, and divides the divided cell mass via the connection part X2. It has the division
- the cell culture device 10 also has a medium supply unit 110 that supplies a medium into the circulation flow path F1.
- the cell culture device 10 By configuring the cell culture device 10 as described above, it is possible to continuously perform a series of processes required for cell culture such as medium exchange processing and division processing in a closed system. This enables mass production of homogeneous cells. According to the cell culture device 10 according to the exemplary embodiment, a series of processes necessary for cell culture from the culture start process to the freezing process can be performed without human intervention.
- the control unit 18 has the open / close valves V1 to V5, V11 to V16, V21, V22, V31 and V41, the pumps P1 to P5, the pressure adjustment mechanisms 26 and 33, and Although the case where the process from the culture start process to the freezing process is automated by controlling the operation of 43 is illustrated, it is not limited to this mode.
- the user may manually operate the on-off valves V1 to V5, V11 to V16, V21, V22, V31 and V41, the pumps P1 to P5, and the pressure adjusting mechanisms 26, 33 and 43.
- M represents a molar concentration
- 1M 1 mol / L.
- PBS phosphate buffered saline
- IMDM Iscove's Modified Dulbecco's Medium
- sphere means a spherical cell mass
- ⁇ Material> [Human induced pluripotent stem cell line (hiPS cell line)] -253G1. Sold for sale from iPS Portal Co., Ltd. (5-4 Sakurai-cho, Kawaramachi-dori, Kamigyo-ku, Kyoto-shi, Kyoto).
- [Culture medium] -Medium 1 50 mL of 3% methylcellulose solution was added to 450 mL of TeSR-E8, and the mixture was stirred well. A 10 mM Y-27632 solution was prepared by adding the final concentration of Y-27632 to 10 ⁇ M.
- Medium 2 50 mL of 3% methylcellulose solution was added to 450 mL of TeSR-E8, and the mixture was stirred well to prepare.
- the meshes (1) to (6) were observed with a phase contrast microscope (IX73 manufactured by Olympus Corporation) at a magnification of 20 times, and the opening size of the mesh was obtained by measuring two sides of the opening and averaging them.
- the opening size of the mesh was as follows. -Mesh (1): Opening size 25.7 ⁇ m -Mesh (2): Opening size 35.9 ⁇ m Mesh (3): Opening size 40.5 ⁇ m Mesh (4): Opening size 43.3 ⁇ m Mesh (5): Opening size 73.1 ⁇ m Mesh (6): Opening size 100.1 ⁇ m
- the hiPS cell line 253G1 was suspended in a 6-well culture dish and medium 2 in an incubator at 37 ° C. and 5% CO 2 for 5 days while changing the medium to form spheres.
- the 15 mL centrifuge tube was centrifuged (50 rpm, 2 minutes) to remove the supernatant, and then the medium 1 previously heated to 37 ° C. was added, and the spheres were resuspended in the medium 1.
- the sphere suspension was transferred to another 15 mL centrifuge tube containing medium 1 (liquid temperature: 37 ° C.) to prepare a sphere suspension with a cell concentration of 5 ⁇ 10 5 / mL.
- Meshes (1) to (6) were attached to the mouths of 15 mL centrifuge tubes or 50 mL centrifuge tubes, respectively.
- the tip of the pipette tip connected to the syringe containing the sphere suspension was pressed against the mesh, the syringe pump was operated to push out the sphere suspension, the sphere suspension was passed through the mesh, and the sphere was divided.
- the mesh passing speed of the sphere suspension was changed by controlling the flow rate with a syringe pump.
- the 6-well culture dish On the first day of culture after passage (ie, 24 hours after passing through the mesh), the 6-well culture dish is removed from the incubator, the well is moved in a circle, the sphere is collected in the center of the well, and a 15 mL centrifuge tube is collected. Moved to. 3 mL of TeSR-E that was pre-warmed to 37 ° C. was placed in the well, and the spheres remaining in the well were collected and transferred to a 15 mL centrifuge tube.
- the medium 2 previously warmed to 37 ° C. is put in an equal amount to the medium before replacement, and the spheres are resuspended, and the medium is changed. It was.
- the sphere suspension was returned to the well, and the culture was continued in an incubator under conditions of 37 ° C. and 5% CO 2 .
- Classification A The sphere has a clear outline, the outline is smooth, and the sphere is spherical.
- Classification D The outline of the sphere is not clear, the outline is uneven, and the sphere has an irregular shape.
- Classification E The sphere is excessively divided by passage, and the size of the sphere is too small.
- FIG. 9 is a sphere image after passage through the mesh (4) at a speed of 100 cm / s, and is a typical example of classification A of the sphere shape.
- FIG. 10 is a sphere image after passing through the mesh (6) at a speed of 180 cm / s and is a typical example of the sphere shape classification D.
- FIG. 11 is a sphere image after passing through the mesh (1) at a speed of 15 cm / s, and is a typical example of classification E of the sphere shape.
- Classification G1 X / Y is more than 1 and less than 3, the shape of the sphere is classification A, the cell recovery rate at passage is 0.40 or more, and the cell proliferation rate after passage 5 is 3.0. That's it.
- Classification G2 Same as classification G1, except that X / Y exceeds 3.
- Classification NG Not applicable to classification G1 or classification G2.
- the passage method of pluripotent stem cells is a passage method suitable for mass culture.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Transplantation (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本例示的実施形態に適用可能な多能性幹細胞は、未分化状態を保持したまま増殖できる「自己複製能」と三胚葉系列すべてに分化できる「多分化能」とを有する未分化細胞であれば特に制限されない。多能性幹細胞としては、例えば、胚性幹細胞(embryonic stem cell;ES細胞)、人工多能性幹細胞(induced pluripotent stem cell;iPS細胞)、胚性生殖細胞(embryonic germ cell;EG細胞)、胚性癌細胞(embryonal carcinoma cell;EC細胞)、多能性成体前駆細胞(multipotent adult progenitor cell;MAP細胞)、成体多能性幹細胞(adult pluripotent stem cell;APS細胞)、Muse細胞(multi-lineage differentiating stress enduring cell)などが挙げられる。本例示的実施形態に適用する多能性幹細胞としては、ES細胞およびiPS細胞が好ましい。
以下に、本開示の例示的実施形態に係る培養工程について説明する。本例示的実施形態において、多能性幹細胞は、浮遊培養により増殖されることが好ましい。具体的には、培養容器に、多能性幹細胞を培地とともに充填して、多能性幹細胞の細胞塊の円相当直径の平均値が例えば、200μm~300μmとなるまで浮遊培養する。なお、円相当直径とは、抽出した細胞塊の各々の輪郭線によって画定される領域を、同じ面積を有する円とみなした場合の円の直径をいう。細胞塊の円相当直径の平均値を300μm以下とすることで、細胞が分泌するサイトカイン等が形成する微小環境による分化誘導を抑制することができる。また、細胞塊の中心部で起こる細胞の壊死を抑制し、生細胞の回収率の低下を抑制できる。一方、細胞塊の円相当直径の平均値を200μm以上とすることで、細胞の回収率を一定以上とすることができる。なお、培養工程において得る細胞塊のサイズは、分化誘導の抑制、細胞の壊死、細胞の回収率などを勘案して適宜変更することが可能である。
以下に、多能性幹細胞の継代を行う際に実施される本開示の例示的実施形態に係る分割工程について説明する。分割工程では、上記の培養工程にて円相当直径の平均値が200μm~300μmとなるまで成長した多能性幹細胞の細胞塊が、より小さいサイズの細胞塊に分割される。
1<X/Y<3 ・・・(1)
細胞供給部100は、細胞培養装置10による培養の対象となる細胞を凍結させた状態で収容する細胞収容部101と、細胞収容部101に収容された細胞を、配管c1を含んで構成される流路F3に送出するポンプP1とを有する。また、細胞供給部100は、細胞収容部101と配管c1とを接続する配管の、ポンプP1の下流側に設けられた開閉バルブV1を有する。細胞収容部101に収容された細胞は、ポンプP1が駆動され、開閉バルブV1が開状態とされることにより流路F3に送出される。
培地供給部110は、細胞の培養に使用する培地(培養液)を収容する培地収容部111および114と、培地収容部111および114にそれぞれ収容された培地を、流路F3に送出するポンプP2およびP3と、ポンプP2およびP3からそれぞれ送出された培地を除菌するためのフィルタ113および116とを有する。また、培地供給部110は、培地収容部111と配管c1とを接続する配管の、フィルタ113の下流側に設けられた開閉バルブV2と、培地収容部114と配管c1とを接続する配管の、フィルタ116の下流側に設けられた開閉バルブV3とを有する。このように、本例示的実施形態に係る培地供給部110は、培地収容部111、ポンプP2、フィルタ113および開閉バルブV2を含む第1の系統と、培地収容部114、ポンプP3、フィルタ116および開閉バルブV3を含む第2の系統と、からなる2系統の培地供給機能を備えており、互いに異なる2種類の培地が供給可能である。なお、培地供給部110における系統の数は、細胞の培養プロトコル等に応じて適宜増減することが可能である。すなわち、培地供給部110を、3種類以上の培地を供給可能とする構成としてもよいし、1種類の培地を供給可能とする構成としてもよい。培地収容部111に収容された培地は、ポンプP2が駆動され、開閉バルブV2が開状態とされることにより流路F3に送出される。培地収容部114に収容された培地は、ポンプP3が駆動され、開閉バルブV3が開状態とされることにより流路F3に送出される。
希釈液供給部120は、細胞の培養過程において適宜実施される希釈処理に用いられる希釈液を収容する希釈液収容部121と、希釈液収容部121に収容された希釈液を、流路F3に送出するポンプP4と、ポンプP4から送出された希釈液を除菌するためのフィルタ123とを有する。また、希釈液供給部120は、希釈液収容部121と配管c1とを接続する配管の、フィルタ123の下流側に設けられた開閉バルブV4を有する。希釈液収容部121に収容された希釈液は、ポンプP4が駆動され、開閉バルブV4が開状態とされることにより流路F3に送出される。
凍結液供給部130は、培養された細胞を凍結部17において凍結保存する場合に用いられる凍結液を収容する凍結液収容部131と、凍結液収容部131に収容された凍結液を、流路F3に送出するポンプP5と、ポンプP5から送出された凍結液を除菌するためのフィルタ133とを有する。また、凍結液供給部130は、凍結液収容部131、ポンプP5およびフィルタ133を接続する配管の、フィルタ133の下流側に設けられた開閉バルブV5を含む。凍結液収容部131に収容された凍結液は、ポンプP5が駆動され、開閉バルブV5が開状態となることにより流路F3に送出される。なお、培養された細胞を凍結保存する必要がない場合には、細胞培養装置10において凍結液供給部130を省略することが可能である。
培養容器20は、細胞供給部100から供給される細胞を、培地供給部110から供給される培地とともに収容し、収容された細胞を培養するための容器である。培養容器20の形態は、特に限定されず、例えば、ガラス製またはステンレス製の容器やプラスチック製のバッグの形態を有する容器を使用することが可能である。培養容器20は、細胞および培地を培養容器20内に流入させるための流入口21と、培養容器20に収容された細胞および培地を培養容器20の外部に流出させるための流出口22と、を有する。
細胞培養装置10は、培養容器20の流出口22と流入口21とを接続する配管a1~a7を含んで構成される循環流路F1を有する。培養容器20に収容された細胞および培地は、培養過程において、循環流路F1内を循環する。循環流路F1内を流れる細胞および培地は、流入口21を経由して培養容器20内へ流入し、培養容器20の内部に収容された細胞および培地は、流出口22を経由して循環流路F1内に流出する。
貯留容器30は、循環流路F1内、すなわち、循環流路F1の途中に設けられている。貯留容器30は、循環流路F1内を流れる細胞、培地、希釈液および凍結液を一時的に貯留するための容器であり、培養期間中に実施される後述する培養開始処理、培地交換処理、分割処理および凍結処理において使用される。貯留容器30の形態は、特に限定されず、例えば、ガラス製またはステンレス製の容器、プラスチック製のバッグの形態を有する容器を使用することが可能である。
分割処理部40は、流路F2内、すなわち、流路F2の途中に設けられている。分割処理部40は、培養容器20内において、図1Aに示す上記の分割装置400を備える。分割処理部40は、循環流路F1から接続部位X1を経由して流路F2内に流入する細胞塊を分割装置400において分割する。分割処理が施された細胞は、接続部位X2を経由して循環流路F1内に流出する。
細胞培養装置10は、循環流路F1内における、貯留容器30の流出口32と培養容器20の流入口21との間であって、接続部位X1よりも上流側(貯留容器30寄り)に位置する接続部位X4において、循環流路F1に接続された配管d1を含んで構成される流路F4を有する。流路F4の端部には、廃液回収容器16が設けられている。廃液回収容器16は、循環流路F1から接続部位X4を経由して流路F4内に流入する廃液を回収するための容器である。廃液回収容器16に回収される廃液には、使用済みの培地、使用済みの希釈液、細胞供給部100から凍結状態で供給される細胞に随伴する凍結液等が含まれる。廃液回収容器16の形態は、特に限定されず、例えば、ガラス製またはステンレス製の容器、プラスチック製のバッグの形態を有する容器を使用することが可能である。
細胞培養装置10は、接続部位X1において、循環流路F1に接続された配管e1を含んで構成される流路F5を有する。流路F5の端部には、凍結部17が設けられている。凍結部17は、循環流路F1から接続部位X1を経由して流路F5内に流入する細胞を凍結液供給部130から供給される凍結液とともに収容する保存容器17aを有する。保存容器17aは、例えば、バイアル、クライオチューブまたはバッグの形態を有するものであってもよい。凍結部17は、保存容器17aに収容された細胞および凍結液を凍結させるフリーザを含んで構成され得る。また、凍結部17は、液体窒素を充填したタンクを備えていてもよく、タンク内に保存容器17aを収容し得るように構成されていてもよい。また、凍結部17は、例えば、太陽日酸社製のクライオライブラリー(登録商標)システムを含んで構成されていてもよい。流路F5を構成する配管e1には、接続部位X1の近傍において開閉バルブV41が設けられている。開閉バルブV41は、貯留容器30から凍結部17に細胞および凍結液を移送する場合に開状態とされ、それ以外の場合には閉状態とされる。なお、流路F5と循環流路F1との接続位置は、貯留容器30の流出口32と培養容器20の流入口21との間であれば、いかなる位置であってもよい。また、細胞を凍結保存する必要がない場合には、凍結部17を省略することが可能である。
制御部18は、ポンプP1~P5、開閉バルブV1~V5、V11~V16、V21、V22、V31およびV41、ガス供給機構25、圧力調整機構26、33および43の動作を統括的に制御する。これにより、所定の細胞培養プロトコルに沿った細胞の培養が、人手を介在させることなく、自動で実施される。なお、図3において、制御部18と、制御部18によって制御される上記の各構成要素との間の電気的な接続配線は、図面の煩雑さを回避する観点から図示を省略している。
細胞培養装置10は、細胞収容部101に収容された細胞を、培地収容部111および114に収容された培地とともに培養容器20内に収容して細胞培養を開始する培養開始処理を以下のようにして実施する。図4は、細胞培養装置10が培養開始処理を実施する場合における、細胞および培地等の流れを示す図である。なお、図4において、細胞および培地等の流れと、以下に示す各処理ステップとの対応が示されている。
細胞培養においては、細胞から分泌される代謝物などによって培地が変質する。そのため、培養期間内における適切な時期に、培養容器20内における使用済みの培地を、新たな培地に交換する培地交換処理が必要とされる。本例示的実施形態に係る細胞培養装置10は、上記の培地交換処理を、以下のようにして実施する。図5は、細胞培養装置10が培地交換処理を実施する場合における細胞および培地等の流れを示す図である。なお、図5において、細胞および培地等の流れと、以下に示す各処理ステップとの対応が示されている。
多能性幹細胞の培養においては、細胞を培養することによって生じる細胞塊(スフェア)のサイズが過大となると、細胞塊同士が接着融合し、細胞が分化を開始したり、細胞塊の中心部の細胞が壊死したりするといった問題が生じ得る。従って、細胞塊のサイズが過大となることを防止するために、培養期間中の適切な時期に、細胞塊を分割する分割処理が必要となる場合がある。本例示的実施形態に係る細胞培養装置10は、上記の分割処理を、以下のようにして実施する。図6は、細胞培養装置10が分割処理を実施する場合における細胞および培地等の流れを示す図である。なお、図6において、細胞および培地等の流れと、以下に示す各処理ステップとの対応が示されている。
培養された細胞を回収して保存する場合、細胞を保存容器内に回収して凍結保存することが一般的である。本例示的実施形態に係る細胞培養装置10は、培養された細胞を回収して凍結させる凍結処理を、以下のようにして実施する。図7は、細胞培養装置10が凍結処理を実施する場合における細胞および培地等の流れを示す図である。なお、図7において、細胞および培地等の流れと、以下に示す各処理ステップとの対応が示されている。
細胞培養装置10は、制御部18が以下に例示する細胞培養処理プログラムを実行することにより、細胞培養を、人手を介在させることなく自動で行うことが可能である。図8は、制御部18が実行する細胞培養プログラムにおける処理の流れを示すフローチャートである。
[ヒト人工多能性幹細胞株(hiPS細胞株)]
・253G1。株式会社iPSポータル(日本国京都府京都市上京区河原町通今出川下る梶井町448番地5)より分譲。
・TeSR-E8、STEMCELL Technologies社の型番ST-05940。
・3%メチルセルロース液(IMDM中。メチルセルロース濃度はw/v%)、R&D Systems社の型番HSC001。
・10mM Y-27632液。Y-27632(ROCK阻害剤、Sigma-Aldrichの型番Y0503)をダルベッコPBS(Ca,Mg不含)に溶解させた溶液。
・培地1:TeSR-E8 450mLに3%メチルセルロース液50mLを加えてよく撹拌し、10mM Y-27632液を、Y-27632の終濃度が10μMとなる量加え調製した。
・培地2:TeSR-E8 450mLに3%メチルセルロース液50mLを加えてよく撹拌し調製した。
・Ultra-Low Attachment Plate、Corning社の型番Costar3471。6ウェル、蓋付き。
・15mL遠心チューブ、Thermo Scientific社の型番339650。
・50mL遠心チューブ、Thermo Scientific社の型番339652。
・メッシュ(1):Sysmex社のPartec CellTrics型番06-04-004-2325。
・メッシュ(2):Sysmex社のPartec CellTrics型番06-04-004-2326。
・メッシュ(3):ベクトン・ディッキンソン社のセルストレーナー型番352340。
・メッシュ(4):Sysmex社のPartec CellTrics型番06-04-004-2327。
・メッシュ(5):ベクトン・ディッキンソン社のセルストレーナー型番352350。
・メッシュ(6):ベクトン・ディッキンソン社のセルストレーナー型番352360。
・メッシュ(1):開口寸法 25.7μm
・メッシュ(2):開口寸法 35.9μm
・メッシュ(3):開口寸法 40.5μm
・メッシュ(4):開口寸法 43.3μm
・メッシュ(5):開口寸法 73.1μm
・メッシュ(6):開口寸法100.1μm
[hiPS細胞の培養]
hiPS細胞株253G1を、6ウェル培養ディッシュと培地2を用い、インキュベータ中、37℃、5%CO2の条件下で、培地を交換しながら5日間浮遊培養し、スフェアを形成した。
5日間の浮遊培養後、6ウェル培養ディッシュをインキュベータから取り出し、円を描くようにウェルを動かして、ウェルの中央にスフェアを集め、15mL遠心チューブに培地ごと移した。予め37℃に加温したTeSR-E8 3mLをウェルに入れ、ウェルに残ったスフェアを集め、さらに15mL遠心チューブに移した。
メッシュを通過させた後のスフェア浮遊液を、6ウェル培養ディッシュに播種し、インキュベータ中、37℃、5%CO2の条件下で培養した。
[継代前のスフェアの大きさ]
上述の[hiPS細胞の継代]において継代のために調製したスフェア懸濁液の一部をウェルに戻し、平面上でウェルを縦及び横に動かして、スフェアをウェル内で均一に分散させた。ウェル内のスフェアを位相差顕微鏡(オリンパス社のIX73)により観察し、倍率10倍の顕微鏡画像を撮影した。無作為に選んだ300個のスフェア像を解析し、個々のスフェア像の面積から円相当直径を求め、300個の平均を求めた。円相当直径の平均は263.4μmであった。
継代1時間後(即ち、メッシュ通過から1時間後)に、6ウェル培養ディッシュをインキュベータから取り出し、平面上でウェルを縦及び横に動かして、スフェアをウェル内で均一に分散させた。ウェル内のスフェアを位相差顕微鏡(オリンパス社のIX73)により観察し、倍率10倍の顕微鏡画像を撮影した。無作為に選んだ300個のスフェア像を解析し、個々のスフェア像の面積から円相当直径を求め、300個の平均を求めた。また、下記のとおり円相当直径によりスフェアを分類し、XとYの比「X/Y」を求めた。
X:円相当直径が30μm以上40μm未満のスフェアの個数。
Y:円相当直径が40μm以上300μm未満のスフェアの個数。
分類A:スフェアの輪郭がはっきりしており、輪郭がなめらかで、スフェアが球形である。
分類D:スフェアの輪郭がはっきりしておらず、輪郭に凹凸があり、スフェアが不規則な形状である。
分類E:継代によってスフェアが過度に分割され、スフェアの大きさが不適当なまでに小さくなっている。
図10は、メッシュ(6)に速度180cm/sで通過させて継代した後のスフェア像であり、スフェアの形状の分類Dの典型例である。
図11は、メッシュ(1)に速度15cm/sで通過させて継代した後のスフェア像であり、スフェアの形状の分類Eの典型例である。
継代操作を開始する直前と、継代1時間後(即ち、メッシュ通過から1時間後)と、継代後の培養5日目(即ち、メッシュ通過から120時間後)に、6ウェル培養ディッシュをインキュベータから取り出し、平面上でウェルを縦及び横に動かして、スフェアをウェル内で均一に分散させた。1mLチューブにスフェア分散液を300μLとり、700μLのTeSR-E8を加えて遠心処理(4000rpm、3分間)して上清を取り除いた。次いで、300μLのTrypLE Select(トリプシン様酵素、Gibco社の型番12563)を添加し、ボルテックスミキサーで撹拌し、37℃で3分間静置後に再度ボルテックスミキサーで撹拌し、細胞懸濁液を得た。細胞懸濁液を細胞計数装置(ChemoMetec社のNC-200)にかけて細胞数を測定し、下記の式(2)により細胞回収率を算出し、下記の式(3)により継代5日後の細胞増殖率を算出した。
式(3):継代5日後の細胞増殖率=継代5日後の細胞数÷継代1時間後の細胞数
分類G1:X/Yが1超3未満であり、スフェアの形状が分類Aであり、継代時の細胞回収率が0.40以上であり、継代5日後の細胞増殖率が3.0以上である。
分類G2:X/Yが3を超えること以外は、分類G1と同じである。
分類NG:分類G1及び分類G2に当てはまらない。
Claims (4)
- 多能性幹細胞を培養して細胞塊を得る培養工程と、
前記細胞塊を15cm/sec以上150cm/sec以下の速度で、各々の開口寸法が30μm以上80μm以下である複数の貫通孔を有するメッシュ状の膜に通すことにより、前記細胞塊を分割する分割工程と、
を含む多能性幹細胞の継代方法。 - 前記培養工程において、前記多能性幹細胞を、高分子化合物を含有する培養液中で培養する、請求項1に記載の継代方法。
- 前記分割工程において、分割後の細胞塊の円相当直径の平均値を30μm以上75μm以下とする、請求項1または請求項2に記載の継代方法。
- 前記多能性幹細胞がES細胞またはiPS細胞である、請求項1から請求項3のいずれか1項に記載の継代方法。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018515429A JP6653753B2 (ja) | 2016-05-06 | 2017-04-24 | 多能性幹細胞の継代方法 |
CN201780027882.2A CN109153972B (zh) | 2016-05-06 | 2017-04-24 | 多能干细胞的传代方法 |
EP17792708.4A EP3453753B1 (en) | 2016-05-06 | 2017-04-24 | Method for subculturing pluripotent stem cells |
KR1020187032237A KR102136478B1 (ko) | 2016-05-06 | 2017-04-24 | 다능성 줄기 세포의 계대 방법 |
US16/180,005 US20190078058A1 (en) | 2016-05-06 | 2018-11-05 | Method for subculturing pluripotent stem cells |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016-093300 | 2016-05-06 | ||
JP2016093300 | 2016-05-06 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/180,005 Continuation US20190078058A1 (en) | 2016-05-06 | 2018-11-05 | Method for subculturing pluripotent stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017191775A1 true WO2017191775A1 (ja) | 2017-11-09 |
Family
ID=60202987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2017/016249 WO2017191775A1 (ja) | 2016-05-06 | 2017-04-24 | 多能性幹細胞の継代方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20190078058A1 (ja) |
EP (1) | EP3453753B1 (ja) |
JP (1) | JP6653753B2 (ja) |
KR (1) | KR102136478B1 (ja) |
CN (1) | CN109153972B (ja) |
WO (1) | WO2017191775A1 (ja) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019146502A (ja) * | 2018-02-26 | 2019-09-05 | 株式会社Ihi | 細胞分割装置及び細胞培養装置 |
WO2020032042A1 (ja) * | 2018-08-06 | 2020-02-13 | 日産化学株式会社 | 細胞塊を分割するためのデバイス、および、それを用いて細胞塊を分割する方法 |
WO2020032041A1 (ja) * | 2018-08-06 | 2020-02-13 | 日産化学株式会社 | 細胞培養システム、および、それを用いた細胞塊の製造方法 |
WO2020039911A1 (ja) * | 2018-08-20 | 2020-02-27 | 富士フイルム株式会社 | 細胞培養方法及び細胞培養装置 |
WO2020044984A1 (ja) * | 2018-08-27 | 2020-03-05 | 富士フイルム株式会社 | 細胞培養方法及び細胞培養装置 |
WO2020071209A1 (ja) * | 2018-10-02 | 2020-04-09 | 富士フイルム株式会社 | 細胞培養方法 |
JPWO2020184350A1 (ja) * | 2019-03-08 | 2020-09-17 | ||
WO2020262351A1 (ja) * | 2019-06-28 | 2020-12-30 | アイ ピース, インコーポレイテッド | 細胞塊分割器、細胞塊分割器の製造方法、及び細胞塊の分割方法 |
WO2021145320A1 (ja) * | 2020-01-14 | 2021-07-22 | 味の素株式会社 | 細胞の培養方法 |
WO2023145922A1 (ja) * | 2022-01-31 | 2023-08-03 | 株式会社ヘリオス | ナチュラルキラー細胞の製造方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004129550A (ja) * | 2002-10-09 | 2004-04-30 | Asahi Medical Co Ltd | 単球の分離回収方法 |
JP2010526530A (ja) * | 2007-05-04 | 2010-08-05 | スンドストローム,エリック | スライシングデバイス |
WO2013077423A1 (ja) * | 2011-11-25 | 2013-05-30 | 国立大学法人京都大学 | 多能性幹細胞の培養方法 |
WO2014136581A1 (ja) * | 2013-03-06 | 2014-09-12 | 国立大学法人京都大学 | 多能性幹細胞の培養システム及び多能性幹細胞の継代方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2949746A4 (en) * | 2013-01-23 | 2016-07-27 | Tokyo Electron Ltd | METHOD OF SUB-CULTURE OF PLURIPOTENT STEM CELLS |
JP6268342B2 (ja) * | 2016-04-27 | 2018-01-31 | 株式会社ジェイテックコーポレーション | 大量細胞培養システム及びそれに用いる回転細胞培養装置 |
-
2017
- 2017-04-24 WO PCT/JP2017/016249 patent/WO2017191775A1/ja unknown
- 2017-04-24 EP EP17792708.4A patent/EP3453753B1/en active Active
- 2017-04-24 CN CN201780027882.2A patent/CN109153972B/zh active Active
- 2017-04-24 JP JP2018515429A patent/JP6653753B2/ja active Active
- 2017-04-24 KR KR1020187032237A patent/KR102136478B1/ko active IP Right Grant
-
2018
- 2018-11-05 US US16/180,005 patent/US20190078058A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004129550A (ja) * | 2002-10-09 | 2004-04-30 | Asahi Medical Co Ltd | 単球の分離回収方法 |
JP2010526530A (ja) * | 2007-05-04 | 2010-08-05 | スンドストローム,エリック | スライシングデバイス |
WO2013077423A1 (ja) * | 2011-11-25 | 2013-05-30 | 国立大学法人京都大学 | 多能性幹細胞の培養方法 |
WO2014136581A1 (ja) * | 2013-03-06 | 2014-09-12 | 国立大学法人京都大学 | 多能性幹細胞の培養システム及び多能性幹細胞の継代方法 |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019146502A (ja) * | 2018-02-26 | 2019-09-05 | 株式会社Ihi | 細胞分割装置及び細胞培養装置 |
WO2020032042A1 (ja) * | 2018-08-06 | 2020-02-13 | 日産化学株式会社 | 細胞塊を分割するためのデバイス、および、それを用いて細胞塊を分割する方法 |
WO2020032041A1 (ja) * | 2018-08-06 | 2020-02-13 | 日産化学株式会社 | 細胞培養システム、および、それを用いた細胞塊の製造方法 |
JPWO2020039911A1 (ja) * | 2018-08-20 | 2021-08-10 | 富士フイルム株式会社 | 細胞培養方法及び細胞培養装置 |
WO2020039911A1 (ja) * | 2018-08-20 | 2020-02-27 | 富士フイルム株式会社 | 細胞培養方法及び細胞培養装置 |
JP7053853B2 (ja) | 2018-08-20 | 2022-04-12 | 富士フイルム株式会社 | 細胞培養方法及び細胞培養装置 |
WO2020044984A1 (ja) * | 2018-08-27 | 2020-03-05 | 富士フイルム株式会社 | 細胞培養方法及び細胞培養装置 |
WO2020071209A1 (ja) * | 2018-10-02 | 2020-04-09 | 富士フイルム株式会社 | 細胞培養方法 |
JPWO2020184350A1 (ja) * | 2019-03-08 | 2020-09-17 | ||
JPWO2020262351A1 (ja) * | 2019-06-28 | 2020-12-30 | ||
JP7037141B2 (ja) | 2019-06-28 | 2022-03-16 | アイ ピース,インコーポレイテッド | 細胞塊分割器、細胞塊分割器の製造方法、及び細胞塊の分割方法 |
WO2020262351A1 (ja) * | 2019-06-28 | 2020-12-30 | アイ ピース, インコーポレイテッド | 細胞塊分割器、細胞塊分割器の製造方法、及び細胞塊の分割方法 |
WO2021145320A1 (ja) * | 2020-01-14 | 2021-07-22 | 味の素株式会社 | 細胞の培養方法 |
WO2023145922A1 (ja) * | 2022-01-31 | 2023-08-03 | 株式会社ヘリオス | ナチュラルキラー細胞の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
KR102136478B1 (ko) | 2020-07-21 |
EP3453753A1 (en) | 2019-03-13 |
CN109153972A (zh) | 2019-01-04 |
EP3453753A4 (en) | 2019-09-04 |
US20190078058A1 (en) | 2019-03-14 |
KR20180132836A (ko) | 2018-12-12 |
CN109153972B (zh) | 2023-05-16 |
EP3453753B1 (en) | 2020-10-14 |
JP6653753B2 (ja) | 2020-02-26 |
JPWO2017191775A1 (ja) | 2019-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017191775A1 (ja) | 多能性幹細胞の継代方法 | |
US10479971B2 (en) | Cell culture device and cell culture method | |
US10100277B2 (en) | Pluripotent stem cell expansion and passage using a stirred tank bioreactor | |
JP6987811B2 (ja) | 細胞の凍結保存方法 | |
AU2002243980C1 (en) | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells | |
JP6512662B2 (ja) | 未分化性維持培養材料 | |
TW201400613A (zh) | 細胞培養系統及細胞培養方法 | |
JP6943449B2 (ja) | 撹拌タンクバイオリアクタを用いた多能性幹細胞の増殖および継代 | |
AU2016361442A1 (en) | Large scale cell manufacture system | |
US20210009943A1 (en) | Method for continuous culture of shrimp cells | |
JPWO2013061859A1 (ja) | 細胞濃縮液の製造方法 | |
CN102703377A (zh) | 一种提高动物体外胚胎囊胚发育率的方法 | |
JP2017012109A (ja) | 細胞培養容器、細胞培養装置および細胞培養方法 | |
JP6422221B2 (ja) | 多能性幹細胞からなる細胞塊製造方法 | |
JP2010022269A (ja) | 細胞の保存方法及びその装置 | |
JP7105487B2 (ja) | 凍結移植体及び凍結移植体の製造方法 | |
JP2018201340A (ja) | 歯髄組織の保存方法および保存歯髄組織からの幹細胞の培養方法 | |
Taub | Rabbit Cortical Epithelial Cells | |
WO2019211383A1 (en) | Production of megakaryocytes in bioreactors | |
JP2018064486A (ja) | 歯髄幹細胞の培養方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2018515429 Country of ref document: JP Kind code of ref document: A Ref document number: 20187032237 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17792708 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2017792708 Country of ref document: EP Effective date: 20181206 |